(Press-News.org) Hamilton, ON (March 9, 2023) – McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).
The standard treatment for OSA is a positive airway pressure (PAP) mask that uses compressed air to support lung airways during sleep. However, some people with OSA still experience EDS and may benefit from anti-fatigue medication.
Zeraatkar and Pitre published their results in the Annals of Internal Medicine.
“The most important thing that people with OSA should do is use their PAP machine, but if they are still sleepy there are options in the form of medications that can reduce their tiredness,” said first author Tyler Pitre, a resident physician in internal medicine at McMaster University and incoming respirology fellow at the University of Toronto.
“Fifteen to 30 per cent of people in North America have a diagnosis of OSA and the prevalence could be much higher as many others are undiagnosed. Many people have symptoms as the condition is highly associated with obesity, which affects a large and increasing number of people in Canada, the United States and other high-income countries,” he said.
“Among those patients, many will have EDS, which affects their quality of life, making them less productive and also puts them at risk of other psychological issues. Improving this situation is of paramount importance to physicians.”
Pitre said that OSA affects nearly one billion people globally, leaving many of them at risk of EDS.
Zeraatkar and Pitre made their findings by conducting a systematic review of 14 clinical trials of anti-fatigue medications involving 3,085 people, as well as analysing data from MEDLINE, CENTRAL, EMBASE and ClinicalTrials.gov in a specific network meta-analysis. They conducted their research from October 2022 to January 2023.
Senior author Zeraatkar said that while solriamfetol is likely the best medication for EDS, the drugs armodafinil–modafinil and pitolisant are also effective in combatting fatigue.
Solriamfetol can also raise blood pressure, especially risky for people with OSA, as many of them also have cardiovascular issues.
“It would be interesting to see how effective these anti-fatigue medications will be for treating related illnesses such as chronic fatigue syndrome and long COVID, now that we know they work for a similar condition,” said Zeraatkar, an assistant professor of the Department of Anesthesia.
No external funding was received for this study.
-30-
Editors:
Post-embargo link to the paper: https://www.acpjournals.org/doi/10.7326/M22-3473
Photos of Dena Zeraatkar and Tyler Pitre can be found here: https://bit.ly/44xeBbC
For more information, please contact:
Veronica McGuire
Media Relations
Faculty of Health Sciences
McMaster University
289-776-6952
vmcguir@mcmaster.ca
END
McMaster researchers find best treatment for excessive daytime sleepiness
2023-05-09
ELSE PRESS RELEASES FROM THIS DATE:
Study discovers long COVID risk and symptoms vary in different populations
2023-05-09
The study, published April 7 in Nature Communications, analyzed electronic health records as part of the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative to better understand the persistence of symptoms after SARS-CoV-2 infection, also known as long COVID, among broad, diverse populations. Led by Dr. Rainu Kaushal, chair of the Department of Population Health Sciences at Weill Cornell Medicine and physician-in-chief of population health sciences at New York-Presbyterian ...
Renowned Scripps Research professor Jeffery Kelly elected to National Academy of Sciences
2023-05-09
LA JOLLA, CA—Jeffery Kelly, PhD, the Lita Annenberg Hazen Professor of Chemistry at Scripps Research, has been elected to the National Academy of Sciences for his work on understanding protein shapes and controlling the ensemble of shapes with small molecules in order to develop therapeutic strategies for a range of devastating diseases. The academy awards membership in recognition of “distinguished and continuing achievements in original research.”
The election of Kelly brings the total number of memberships held by Scripps Research faculty in the National Academies of Sciences, Medicine and Engineering to 31.
“This ...
How the ancient messengers cAMP and cGMP deliver their messages
2023-05-09
Two highly similar molecules with essential, but often contrasting, signaling roles in most life forms exert their distinct effects through subtle differences in their bindings to their signaling partners, according to a new study led by researchers at Weill Cornell Medicine.
In the study, published March 27 in Nature Structural & Molecular Biology, the researchers used exquisitely sensitive measurement techniques to reveal at the single-molecule level how the signaling molecules cAMP and cGMP bind to an ion channel from the pacemaker channel family, one of the major types of proteins whose activities they regulate.
Ion channels are common features of cell membranes, ...
Researchers map the immunology of the gut in children with IBD
2023-05-09
Researchers from Karolinska Institutet and Sachs’ Children and Youth Hospital in Sweden have mapped the immune system in the gut of children with inflammatory bowel disease (IBD). The results, which were published in Cell Reports Medicine, can be used to design more targeted therapies.
Today, we know relatively little about how the immune system functions in children with IBD and how this differs from adults. About 40 percent of patients, including both children and adults, do not respond to the treatments that are currently available. It is therefore very important to identify biomarkers that can both predict ...
Extending the life of a lithium metal anode using a protective layer made of an extremely tough gel electrolyte
2023-05-09
A National Institute for Materials Science (NIMS) research team has succeeded in substantially improving the cycling performance of a lithium metal battery by developing a mechanically very strong polymeric gel electrolyte and integrating it into the battery as a layer to protect the lithium metal anode. This achievement may greatly facilitate efforts to put lithium metal anodes—a potentially very high performance anode material—into practical use.
Today’s society is rapidly transforming through the widespread use of digital technologies, the increasing popularity of electric vehicles and the growing use of renewable energy. These ...
MTJ device with the world’s highest TMR performance developed through precision interfacial control
2023-05-09
The National Institute for Materials Science (NIMS) has achieved a tunnel magnetoresistance (TMR) ratio of 631% at room temperature, breaking the previous world record which had stood for 15 years. This was accomplished by fine-tuning the interfaces in a magnetic tunnel junction (MTJ). This MTJ exhibited very large TMR ratio oscillation effect with a peak-to-valley (PV) difference of 141%. This phenomenon may be exploitable to significantly increase the sensitivity of magnetic sensors and the capacity of magnetoresistive random access ...
Scientists use gene-editing technology to produce first calf resistant to major viral disease
2023-05-09
CLAY CENTER, Neb., May 9, 2023 -Scientists have collaborated to produce the first gene-edited calf with resistance to bovine viral diarrhea virus (BVDV), a virus that costs the U.S. cattle sector billions of dollars annually.
The recent study published in PNAS Nexus results from a collaboration between the USDA’s Agricultural Research Service (ARS), the University of Nebraska–Lincoln (UNL), the University of Kentucky, and industry partners, Acceligen and Recombinetics, Inc.
BVDV is one of the most significant viruses ...
Gene-edited calf may reduce reliance on antimicrobials against cattle disease
2023-05-09
Cattle worldwide face major health threats from a highly infectious viral disease that decades of vaccinations and other precautions have failed to contain. Federal, private-sector and Husker scientists are collaborating on a new line of defense, by producing a gene-edited calf resistant to the virus.
If follow-up research confirms its efficacy, the gene-editing approach offers long-term potential to reduce antimicrobial and antibiotic use in the cattle industry.
The bovine viral diarrhea virus (BVDV) devastates the bovine immune system and can cause severe respiratory and intestinal harm to infected beef and dairy cattle, said veterinary epidemiologist Brian Vander ...
Scientists at uOttawa streamline a widely used chemical reaction, creating new manufacturing opportunities
2023-05-09
A team of scientists from the University of Ottawa has developed an innovative technique to manufacture complex chemical structures from easily accessible substrates, making it one of the simplest and most practical methods for converting alcohols into their arylated equivalents.
This innovative method for performing the reaction, namely the deoxygenative Suzuki-Miyaura arylation of aliphatic alcohols, uses two distinct metal catalysts. Their reaction operates under mild reaction conditions with minimal waste products and is expected to have a significant impact on the creation of new molecules. As a result, it will contribute to advances in pharmaceutical, agrochemical, ...
Designing cameras for harsh environments? Be sure to account for lens mount details
2023-05-09
Cameras used in harsh environments must be designed in a way that prevents temperature swings from influencing their optical performance. New research demonstrates that accounting for the exact lens mounting structure used is a critical step in ensuring that lens systems remain robust to temperature changes.
Eric M. Schiesser from Synopsys, Inc. will present the new research at the Optica Design and Fabrication Conference, which will take place 04 – 08 June 2023 in Quebec City, Canada.
“Most optical systems – from the camera in your smartphone to the eyes of the Mars rover - are used over a range of temperatures. To keep the image sharp ...